Cephalon Sues To Block Travelers' $17M Actiq Coverage Claim
By Sindhu Sundar ( July 13, 2012, 9:58 PM EDT) -- Teva Pharmaceutical Industries Ltd. unit Cephalon Inc. on Thursday hit the Travelers Companies Inc. with a suit to block the insurer from trying to recoup some $17 million it claims it paid to cover prescriptions for off-label uses of cancer pain medication Actiq....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.